NEW YORK, June 2 (Reuters) - Acorda Therapeutics Inc. on Monday said it will seek U.S. approval early next year for the first medicine to improve walking for patients with multiple sclerosis, lifting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback